HCV Interview with Sanjeev Arora, MD, Project ECHO Founder

Your daily dose of clinical news you may have missed.

Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.

Timely initiation of DAA treatment, regardless of insurance type, is crucial in reducing HCV-related death, disparity, and transmission, concluded CDC researchers.

IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is increasing and early detection is critical. Brush up on basics with our slides.